![[CONFERENCE] - Fusion Energy: billions in private cash is flooding into fusion, will it pay off?](https://static.wixstatic.com/media/nsplsh_95762ec45dcf44a49eaa6a40d8ba675f~mv2.jpg/v1/fill/w_1789,h_1000,fp_0.50_0.50,q_30,blur_30,enc_avif,quality_auto/nsplsh_95762ec45dcf44a49eaa6a40d8ba675f~mv2.jpg)
![[CONFERENCE] - Fusion Energy: billions in private cash is flooding into fusion, will it pay off?](https://static.wixstatic.com/media/nsplsh_95762ec45dcf44a49eaa6a40d8ba675f~mv2.jpg/v1/fill/w_408,h_228,fp_0.50_0.50,q_90,enc_avif,quality_auto/nsplsh_95762ec45dcf44a49eaa6a40d8ba675f~mv2.jpg)
PhD offer in tumor immunology
- Sep 17, 2021
- 1 min read
Role of B cells and plasma cell subsets in tumor immune surveillance through a comprehensive exploration of tumors associated with paraneoplastic syndromes (PNS)
A PhD position is available within the team “Cancer Immune Surveillance and Therapeutic Targeting” (CISTAR) from the Cancer Research Center of Lyon (CRCL, www.crcl.fr). Interested candidates should submit a motivation letter, CV, master 2 marks and ranking with contact details of 1 or 2 references to Bertrand Dubois (Bertrand.dubois@lyon.unicancer.fr) before October 1st 2021.
Comments